dual CD86 costimulator/GM-CSF gene therapy and vaccine (Radient Pharmaceuticals/Jaiva Technologies)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namedual CD86 costimulator/GM-CSF gene therapy and vaccine (Radient Pharmaceuticals/Jaiva Technologies)
Drug Alias NameGM-CSF/B7-2 gene therapy (AMDL)breast cancer therapy (AMDL)immunogene therapy (AMDL)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMacrophage colony stimulating factor 2 modulatorsCluster of differentiation 86 modulators
TargetsCluster of differentiation 86Macrophage colony stimulating factor 2
Therapy Area/IndicationsSkin NeoplasmsBrain NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRadient Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNuVax Therapeutics IncRadient Pharmaceuticals CorpJaiva Technologies
Active IndicationsN/A
Inactive IndicationsSkin NeoplasmsBrain NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A